Mammaglobin a: a promising marker for breast cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Clinical Chemistry

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINCHEM/48.8.1362PMID 12142396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Uses of Tumor Markers: A Critical Review

  2001cited by this paper
• Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer.

  2001cited by this paper
• Transcriptional Complementarity in Breast Cancer: Application to Detection of Circulating Tumor Cells

  2001cited by this paper
• Mammaglobin is found in breast tissue as a complex with BU101.

  2001cited by this paper
• Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

  2001cited by this paper
• The n e w e n g l a n d j o u r n a l of m e d i c i n e

  2001cited by this paper
• Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy.

  2001cited by this paper
• All Human Genes of the Uteroglobin Family Are Localized on Chromosome 11q12.2 and Form a Dense Cluster

  2000cited by this paper
• Automated assay for HER-2/neu in serum.

  2000cited by this paper
• Combined measurement of the c‐erbb‐2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse

  2000cited by this paper
• Monitoring Therapy by Serum HER-2/Neu

  2000cited by this paper
• Mammaglobin expression in primary, metastatic, and occult breast cancer.

  1999cited by this paper
• Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.

  1999cited by this paper
• Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription‐polymerase chain reaction

  1999cited by this paper
• CA 15-3 and Related Mucins as Circulating Markers in Breast Cancer

  1999cited by this paper
• Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

  1999cited by this paper
• ErbB-2 protein in sera and tumors of breast cancer patients

  1998cited by this paper
• Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes.

  1998cited by this paper
• Identification of mammaglobin B, a novel member of the uteroglobin gene family.

  1998cited by this paper
• Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

  1997cited by this paper
• Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.

  1997cited by this paper
• Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.

  1996cited by this paper
• Isolation of differentially expressed sequence tags from human breast cancer.

  1994cited by this paper
• Humanization of an anti-p185HER2 antibody for human cancer therapy.

  1992cited by this paper
• Detection and quantitation of the human neu oncoprotein

  1991cited by this paper
• The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.

  1991cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper

• Conjugation with S4 protein transduction domain enhances the immunogenicity of the peptide vaccine against breast cancer

  2024cites this paper
• The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma

  2023cites this paper
• FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer.

  2023cites this paper
• Analysis of single-cell RNA-sequencing data identifies a hypoxic tumor subpopulation associated with poor prognosis in triple-negative breast cancer.

  2022cites this paper
• Mammaglobin 1 mediates progression of trastuzumab‐resistant breast cancer cells through regulation of cyclins and NF‐κB

  2022cites this paper
• The aromatase inhibitor letrozole restores FADS2 function in ER+ MCF7 human breast cancer cells.

  2021cites this paper
• Mammaglobin expression in tissue as a predictor of breast carcinoma aggressiveness

  2021cites this paper
• A Network-Based Comparison Between Molecular Apocrine Breast Cancer Tumor and Basal and Luminal Tumors by Joint Graphical Lasso

  2020cites this paper
• Measurement of serum PODXL concentration for detection of pancreatic cancer

  2018cites this paper
• Relationship between Human Mammaglobin mRNA in Peripheral Blood and Overall Survival in Breast Cancer Patients: A Systematic Review and Meta-Analysis

  2017cites this paper
• Detection of Superior Markers for Polymerase Chain Reaction Diagnosis of Breast Cancer Micrometastasis in Sentinel Lymph Nodes.

  2016cites this paper
• Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs

  2016cites this paper
• Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple‐negative tumours

  2016cites this paper
• Mammaglobin in peripheral blood and the tumor of breast cancer patients

  2016cites this paper
• Possible Diagnostic / Prognostic Role Of Survivin And MMP 3 In Breast Cancer Disease

  2015cites this paper
• Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

  2015cites this paper
• Detection of human mammaglobin A mRNA in peripheral blood of breast cancer patients before treatment and association with metastasis.

  2015cites this paper
• Investigation of DNA and RNA markers by novel technologies demonstrates DNA content intratumoral heterogeneity and long non-coding RNA aberrations in breast tumors

  2014cites this paper
• Mammaglobin-A Immunohistochemistry in Primary Central Nervous System Neoplasms and Intracranial Metastatic Breast Carcinoma

  2014cites this paper
• Metasin: An Intra-Operative Real-Time Quantitative Reverse Transcription Polymerase-Chain Reaction (RTqPCR) Assay to Detect Metastatic Breast Cancer in Sentinel Lymph Nodes

  2014cites this paper
• Human mammaglobin in breast cancer: a brief review of its clinical utility

  2014cites this paper
• Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer

  2014cites this paper
• Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients

  2013cites this paper
• Mammaglobin A: review and clinical utility.

  2013cites this paper
• Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

  2013cites this paper
• Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis

  2013cites this paper
• Cancer Biomarkers for Diagnosis, Prognosis and Therapy

  2012cites this paper
• Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient Stratification

  2012cites this paper
• Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.

  2011cites this paper
• Detection of mammaglogin A in blood from breast cancer patients, before and after treatment, using a one-tube nested PCR protocol. Association with the absence of tumor estrogen receptors.

  2011cites this paper
• Expression of human mammaglobin and clinicopathologic correlations in breast cancer: the findings in Malaysia.

  2011cites this paper
• Omics Approaches in Cancer Biomarker and Targeted Anticancer Drug Discovery

  2011cites this paper
• Возможности оценки экспрессии маммаглобина при различной патологии молочной железы. Литературный обзор.

  2010cites this paper
• Gastric tumor from metastasis of breast cancer.

  2010cites this paper
• Molecular and cellular expression of novel genes associated with breast cancer

  2009cites this paper
• Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma.

  2009cites this paper
• Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence

  2009cites this paper
• Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.

  2009cites this paper
• Correlación de mamoglobina con otros biomarcadores de cáncer de seno en una población colombiana

  2009cites this paper
• Is human mRNA mammaglobin-1 a good marker of carcinoma cells in the peripheral blood of patients with breast cancer?

  2008cites this paper
• Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies

  2008cites this paper
• Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.

  2008cites this paper
• Use of a Panel of Novel Genes for Differentiating Breast Cancer from Non-Breast Tissues

  2008cites this paper
• Mammaglobin Expression in the Female Genital Tract: Immunohistochemical Analysis in Benign and Neoplastic Endocervix and Endometrium

  2008cites this paper
• Perspectivas en cáncer de mama: detección de células tumorales circulantes mediante mamaglobina A

  2008cites this paper
• The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer

  2007cites this paper
• Overexpression of mammaglobin B in epithelial ovarian carcinomas.

  2007cites this paper
• The clinical significance of disseminated tumor cells in breast cancer

  2007cites this paper
• Effectiveness of Follow-Up for Breast Cancer Patients

  2006cites this paper
• Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.

  2006cites this paper
• Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

  2006cites this paper
• Lipophilin B: A gene preferentially expressed in breast tissue and upregulated in breast cancer

  2006cites this paper
• Significance, detection and markers of disseminated breast cancer cells.

  2006cites this paper
• Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies

  2006cites this paper
• The characterization of the small breast epithelial mucin (SBEM) gene and protein in human breast cancer

  2005cites this paper
• Evaluation of a Panel ofTumorMarkers forMolecular Detection of CirculatingCancerCells inWomenwithSuspectedBreast Cancer

  2005cites this paper
• Human secretoglobins in normal and neoplastic cells and tissues

  2005cites this paper
• Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

  2005cites this paper
• PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin

  2005cites this paper
• Mammaglobin a in breast cancer: Existence of multiple molecular forms

  2005cites this paper
• Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

  2005cites this paper
• Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.

  2004cites this paper
• Mammaglobin: a candidate diagnostic marker for breast cancer.

  2004cites this paper
• Evidence for the clinical use of tumour markers

  2004cites this paper
• Challenges for Biomarkers in Cancer Detection

  2004cites this paper
• Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients

  2004cites this paper
• Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

  2004cites this paper
• Letter 2: Bone marrow micrometastasis in breast cancer (Br J Surg 2003; 90: 290–301)

  2003cites this paper
• Breast cancer biomarkers and molecular medicine

  2003cites this paper
• Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver (Br J Surg 2003; 90: 306–312)

  2003cites this paper
• Mammaglobin in normal human sweat glands and human sweat gland tumors.

  2003cites this paper
• Cytological , Histological Uni-and Multi-Immunohistochemical Marrow Examinations in Detecting Early Disseminated Tumor Cells in De Novo Breast Cancer Patients

  year unknowncites this paper
• Design and Expression of Recombinant HER-2 Antigen as a Marker for Detection of Breast Cancer

  year unknowncites this paper